Form 4: NeuroOne Medical Technologies Executive Sells Shares to Cover Tax Obligations
SEC Form 4
Steve Mertens, Chief Technology Officer of NeuroOne Medical Technologies, disposed of 1,158 shares of common stock on September 30, 2024, to cover tax obligations.
Summary
- On September 30, 2024, Steve Mertens, the Chief Technology Officer of NeuroOne Medical Technologies Corp, disposed of 1,158 shares of common stock.
- The transaction was executed at a price of $0.99 per share.
- The disposal was conducted to cover tax obligations.
- Following the transaction, Mertens directly owns 173,337 shares of NeuroOne Medical Technologies Corp.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports a stock sale for tax purposes, which is a normal occurrence. It doesn't inherently reflect positive or negative sentiment about the company's future prospects.
Industry Context
Form 4 filings are a routine part of the US stock market and are required by the SEC to ensure transparency of insider transactions. They do not necessarily indicate a negative outlook for the company.
Key Dates
| Date | Description |
|---|---|
| 09/30/2024 | Date of transaction: Steve Mertens disposed of 1,158 shares of common stock. |
| 10/02/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.